ES2188021T3 - Metodo para evitar el uso indebido de un sistema terapeutico percutaneo. - Google Patents

Metodo para evitar el uso indebido de un sistema terapeutico percutaneo.

Info

Publication number
ES2188021T3
ES2188021T3 ES98950053T ES98950053T ES2188021T3 ES 2188021 T3 ES2188021 T3 ES 2188021T3 ES 98950053 T ES98950053 T ES 98950053T ES 98950053 T ES98950053 T ES 98950053T ES 2188021 T3 ES2188021 T3 ES 2188021T3
Authority
ES
Spain
Prior art keywords
therapeutic system
unfault
avoid
percutaneous therapeutic
percutaneous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98950053T
Other languages
English (en)
Inventor
Frank Becher
Ann-Katrin Klink
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2188021T3 publication Critical patent/ES2188021T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Radiation-Therapy Devices (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Sistema terapéutico percutáneo (TTS), que comprende por lo menos una capa que contiene sustancia activa, en particular con revestimiento autoadhesivo, así como por lo menos otra capa posterior impermeable al principio activo, caracterizado por el hecho de que contiene una sustancia terapéuticamente neutra y que no interactúa con el principio activo, de sabor desagradable.
ES98950053T 1997-10-01 1998-09-18 Metodo para evitar el uso indebido de un sistema terapeutico percutaneo. Expired - Lifetime ES2188021T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19743484A DE19743484C1 (de) 1997-10-01 1997-10-01 Transdermales therapeutisches System mit Schutz vor oraler Applikation und Verfahren zum Schutz einer Person vor Kontamination infolge unzulässiger oraler Applikation toxischer Inhaltsstoffe eines transdermalen therapeutischen Systems

Publications (1)

Publication Number Publication Date
ES2188021T3 true ES2188021T3 (es) 2003-06-16

Family

ID=7844345

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98950053T Expired - Lifetime ES2188021T3 (es) 1997-10-01 1998-09-18 Metodo para evitar el uso indebido de un sistema terapeutico percutaneo.

Country Status (23)

Country Link
EP (1) EP1019032B1 (es)
JP (2) JP4755338B2 (es)
KR (1) KR100552102B1 (es)
AT (1) ATE228356T1 (es)
AU (1) AU759609B2 (es)
CA (1) CA2305432C (es)
DE (2) DE19743484C1 (es)
DK (1) DK1019032T3 (es)
ES (1) ES2188021T3 (es)
HK (1) HK1029919A1 (es)
HU (1) HU226644B1 (es)
ID (1) ID24333A (es)
IL (1) IL134479A (es)
MY (1) MY116425A (es)
NO (2) NO319163B1 (es)
NZ (1) NZ503643A (es)
PL (1) PL193066B1 (es)
PT (1) PT1019032E (es)
SK (1) SK3332000A3 (es)
TR (1) TR200000461T2 (es)
TW (1) TW431894B (es)
WO (1) WO1999016428A1 (es)
ZA (1) ZA988904B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19743484C1 (de) * 1997-10-01 1999-01-28 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Schutz vor oraler Applikation und Verfahren zum Schutz einer Person vor Kontamination infolge unzulässiger oraler Applikation toxischer Inhaltsstoffe eines transdermalen therapeutischen Systems
GB0026137D0 (en) * 2000-10-25 2000-12-13 Euro Celtique Sa Transdermal dosage form
US7867511B2 (en) * 2004-01-23 2011-01-11 Travanti Pharma Inc. Abuse potential reduction in abusable substance dosage form
DE102004019916A1 (de) * 2004-04-21 2005-11-17 Grünenthal GmbH Gegen Missbrauch gesichertes wirkstoffhaltiges Pflaster
CN112823191A (zh) * 2018-10-17 2021-05-18 日荣新化株式会社 粘合片及其制造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8804164D0 (en) * 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
US5236714A (en) * 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US5149538A (en) * 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
DE4342174C1 (de) * 1993-12-10 1995-05-11 Lohmann Therapie Syst Lts Transdermales therapeutisches System sowie ein Verfahren zur Herstellung eines transdermalen therapeutischen Systems zur kombinierten transdermalen Anwendung von Physostigmin und Scopolamin für die Prophylaxe und zur Vorbehandlung einer Vergiftung durch hochtoxische phosphororganische Nervengifte, insbesondere Soman und seine Verwendung
DE19743484C1 (de) * 1997-10-01 1999-01-28 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Schutz vor oraler Applikation und Verfahren zum Schutz einer Person vor Kontamination infolge unzulässiger oraler Applikation toxischer Inhaltsstoffe eines transdermalen therapeutischen Systems

Also Published As

Publication number Publication date
HUP0003476A2 (hu) 2001-02-28
DK1019032T3 (da) 2003-03-10
IL134479A0 (en) 2001-04-30
AU9626598A (en) 1999-04-23
AU759609B2 (en) 2003-04-17
MY116425A (en) 2004-01-31
IL134479A (en) 2005-07-25
ID24333A (id) 2000-07-13
ZA988904B (en) 1999-04-12
JP2001517695A (ja) 2001-10-09
PT1019032E (pt) 2003-04-30
TR200000461T2 (tr) 2000-09-21
KR100552102B1 (ko) 2006-02-13
PL193066B1 (pl) 2007-01-31
CA2305432C (en) 2007-04-03
NO20001492L (no) 2000-03-22
HK1029919A1 (en) 2001-04-20
NO20001492D0 (no) 2000-03-22
NO20001691D0 (no) 2000-03-31
WO1999016428A1 (de) 1999-04-08
CA2305432A1 (en) 1999-04-08
PL339736A1 (en) 2001-01-02
JP2009035561A (ja) 2009-02-19
JP4755338B2 (ja) 2011-08-24
ATE228356T1 (de) 2002-12-15
NZ503643A (en) 2003-05-30
DE19743484C1 (de) 1999-01-28
HUP0003476A3 (en) 2001-04-28
DE59806468D1 (de) 2003-01-09
SK3332000A3 (en) 2000-11-07
NO319163B1 (no) 2005-06-27
HU226644B1 (en) 2009-05-28
NO20001691L (no) 2000-03-31
EP1019032A1 (de) 2000-07-19
TW431894B (en) 2001-05-01
EP1019032B1 (de) 2002-11-27
KR20010030886A (ko) 2001-04-16

Similar Documents

Publication Publication Date Title
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
SV2004001556A (es) Preparaciones acidas de insulina con establidad mejorada
DK0971705T3 (da) Lægemiddelformuleringer til hormonerstatningsterapi til lokal påföring på huden
EP0922453A3 (en) Percutaneous absorption type preparation containing tulobuterol
CA2193129A1 (en) Transdermal drug delivery system
KR880012216A (ko) 활성성분 배합물용 경피성 치료계
IE900580L (en) Therapeutic system for the retarded and controlled¹transdermal or transmucous administration of active¹substances (ii)
AU6995700A (en) Therapeutic system containing an active substance for the application on the skin which contains at least two polymerous layers
PT1135163E (pt) Composicao topicas contendo ascomicinas
ES2180774T3 (es) La utilizacion de triacetato de glicerilo para el tratamiento de onicomicosis.
ES2188021T3 (es) Metodo para evitar el uso indebido de un sistema terapeutico percutaneo.
DE50010108D1 (de) Desoxypeganin-tts
AU2001258662A1 (en) Use of a lacrophyl preparation in eye-drops containing therapeutically active compounds
BR9608255A (pt) Sistema terapéutico transdérmico (stt) para a administração de testosterona
YU3390A (sh) Postupak za izradu površinskog terapijskog sistema sa sadržajem antineoplastične aktivne materije, naročito 5-fluor-uracila
AR036321A1 (es) Metodo y formulacion farmaceutica para el tratamiento de la discinesia de aparicion tardia.
DE69706070T2 (de) Zubereitung zur perkutanen verabreichung enthaltend 6-amino-5-chloro-1-isopropyl-2-(4-methyl-1-piperazinyl)benzimidazol
AU2002328873A1 (en) Dosage forms comprising particles containing active ingredient for application on the skin or mucous membrane
AR025391A1 (es) Procedimiento para aplicar a chorro un preparado en fase liquida que contenga un principio activo sobre un sustrato plano
AR011807A1 (es) Una composicion antitranspirante en aerosol sustancialmente anhidra para la aplicacion topica sobre la piel humana, y uso no terapeutico de dicha composicion.
ES2141548T3 (es) Preparado farmaceutico de superficie estabilizada para su aplicacion sobre la piel.
NO20054243L (no) Kombinasjon av desoksypeganin og mecamylamin for behandling av alkoholmisbruk. ion eller et salt derav (forkortelse: NTBC). kseptabelt salt saerlig caspofunginacetat
ES2126308T3 (es) Sistema terapeutico percutaneo a base de estradiol con aditivos hidrofilos.
AR029664A1 (es) Parche portador de estrngenos con reservorio de sustancia activa a base de etilcelulosa y un copolemero de etileno, acetato de vinilo y vinilpirrolidona
CO4370014A1 (es) Soluciones inyectables estables de diritromicina